MRI Interventions, Inc
Memphis, TN 38103
The ClearPoint-® Neuro Navigation System Featured at AANS Practical Clinics for Third Consecutive Year
Surgeons to have unique opportunity for hands-on training with ClearPoint IRVINE, Calif. –Ã- MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint Neuro Navigation System will be utilized in two Practical Clinics at the Annual Meeting of the American Association of Neurological Surgeons (AANS) taking place on April 30 through May 4, 2016, in Chicago, Illinois. Both the...
Read More »MRI Interventions Congratulates Voyager Therapeutics on First Patient Dosing in RESTORE-1, the Phase 2 VY-AADC Gene Therapy Trial for Parkinsonâ™s Disease
IRVINE, Calif. , Dec. 10, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed for navigation, ablation and gene therapy, today announced participation in the RESTORE-1 gene therapy trial for Parkinson’s disease sponsored by Voyager Therapeutics. Under the agreement with Voyager, MRI Interventions provided the navigation system...
Read More »MRI Interventions Congratulates Monteris Medical on FDA Clearance of NeuroBlate Laser Probe
Clearance Resolves Outstanding FDA Advisory Notice Issues IRVINE, Calif., Oct. 24, 2018 (GLOBE NEWSWIRE) -- MRI Interventions (OTCQB:MRIC) congratulates Monteris Medical on the FDA Clearance of its new NeuroBlate Optic Laser Probe. The new probe replaces a previous metallic thermocouple with a non-metallic fiber optic temperature sensor, eliminating risk of unintended probe heating and addressing...
Read More »MRI Interventions Congratulates Axovant on First Patient Dosing in New Gene Therapy Clinical Study for Patients with Parkinsonâ™s Disease
Initial Data Expected in First Half of 2019 IRVINE, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- MRI Interventions (OTCQB:MRIC) congratulates Axovant Sciences Ltd. on the dosing of its first patient in a clinical study of AXO-Lenti-PD, also known as OXB-102, an investigational gene therapy for the treatment of Parkinson’s disease. The dosing was completed using MRI’s SmartFlow® cannulae to...
Read More »MRI Interventions Announces Strategic Agreement with Voyager Therapeutics for Neurosurgical Device Service, Supply and Development
Agreement to include service and support of ClearPoint® and SmartFlow® Devices, and joint-development of new neurosurgical devices IRVINE, Calif., May 15, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced a strategic agreement with Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe...
Read More »The ClearPoint-® Neuro Navigation System Featured at AANS Practical Clinics for Third Consecutive Year
Surgeons to have unique opportunity for hands-on training with ClearPoint IRVINE, Calif. –Ã- MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint Neuro Navigation System will be utilized in two Practical Clinics at the Annual Meeting of the American Association of Neurological Surgeons (AANS) taking place on April 30 through May 4, 2016, in Chicago, Illinois. Both the...
Read More »